BMY Swing Trade

Updated
Bristol-Myers Squibb Co (BMY)

BMY has been on a downtrend since December 2022 but since its recent Dividend payout followed by good earnings, it seems like a reversal of trend is in the making.

Following a month-long consolidation period, a bullish candlestick formation at today's close could indicate a favourable entry point. I anticipate a short-term price movement towards $53.
Trade closed: target reached
TP reached!
Chart PatternsTrend Analysis

Disclaimer